Tag Archives: Events

Always Learning: Networking Opportunities at the BIO International Convention

BIO International Convention

After we wrapped up our last BIO International Convention – we took the time to convene focus groups made up of BIO members, convention attendees, exhibitors and others – to find out what they thought of the event. It is always interesting to get advice back from folks about things you care about – sometimes it is flattering, other times it can open your eyes to issues you had not previously thought about. When we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

My First Blog Entry: An Enlivened Biotech Industry and BIO International Convention

Scott Whitaker

While Washington, DC struggles with yet another round of cold temperatures, inside the halls of BIO, we have turned the heat up and are working hard to make many exciting changes to the 2014 BIO International Convention in SUNNY San Diego. It is more than just California dreaming – our team has been breaking a sweat responding to all of the early registrations for this year’s event (it is how they get into convention shape). Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO CEO Company Snapshot: Conatus Pharmaceuticals

Conatus-Pharma

The Company Snapshots have returned for our next One-on-One Partnering event, the BIO CEO & Investor Conference, taking place in New York City this February. The companies that will be profiled in these snapshots will all be presenting at the event, and we hope this provides the opportunity to learn more about them, and catch up on what’s new. What is your company’s lead product or technology? Conatus’s lead product is emricasan, a first-in-class oral Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Dave Thomas

Is 2014 a good time to invest in biotech? How many biotech IPOs will there be? Which sectors will perform the best? To find out what investors think about these questions and more, BIO is conducting its annual Buy-side Investor Perception Survey and releasing the results at the 16th Annual BIO CEO & Investor Conference in New York, Monday Feb. 10. But as the results are coming in, BIO is hosting the #BIOBuyside Twitter chat Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , ,

Lots of Buzz at the BIO Investor Forum

Event

Thirty-eight biotech IPO’s this year. The NASDAQ Biotechnology Index is up 50 percent YTD.  Are we in a boom or a bubble? At the 12th Annual BIO Investor Forum,  that was the question on everybody’s mind. Nearly 600 biotech industry leaders, investors, and reporters gathered in San Francisco to find business partners, make connections, and hear our panelists discuss everything from Crowdfunding, the GAIN Act, the JOBS Act, and, of course, the booming IPO markets. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,